Everyone will have an access to Covid-19 vaccine due to its affordable pricing.
“I expect there to be differential pricing in certain regions of the world,” he added, declining to elaborate on the different price tags.
According to Homenews.co.ke blog, BioNTech with Pfizer are the firms behind the successful drug that seems to be ready for human use anytime.
“We’ve tried to pursue a balanced approach that recognizes that innovation requires capital and investment so we plan to price our vaccine well below typical market rates reflecting the situation that we’re in and with the goal to insure broad-based access around the world,” Richardson said at the FT event.
This is happening even as task force from the White House is preparing to roll out distribution plans anytime from end month.
Reported by Trained Creative Writer & Online Media Enthusiast -Kenya.
Content created and supplied by: Christbuoy080 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More